Helios

Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 10, 2023

NEWTOWN, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended June 30, 2023.

Key Points: 
  • “We saw a significant increase in sales during the second quarter of 2023, with revenue up 115% over the second quarter of 2022, and up 131% compared to the first quarter of 2023.
  • Selling, general and administrative expenses for the second quarter of 2023 were $2.6 million, comparable to the $2.5 million reported in the second quarter of 2022.
  • Total operating expenses for the second quarter of 2023 decreased to $3.3 million, compared to $3.5 million in the second quarter of 2022.
  • Operating loss for the second quarter of 2023 decreased $0.2 million to a loss of $3.2 million, compared to an operating loss of $3.4 million in the second quarter of 2022.

Helios Technologies Reports Strong Sequential Growth in the Second Quarter 2023 with Revenue Up 7% and Net Income Up 21%

Retrieved on: 
Monday, August 7, 2023

Please carefully review the attached Non-GAAP reconciliations to the most directly comparable GAAP measures and the related additional information provided throughout.

Key Points: 
  • Please carefully review the attached Non-GAAP reconciliations to the most directly comparable GAAP measures and the related additional information provided throughout.
  • Continued Positive Sequential Trends: Total revenue up 7%, Electronics segment revenue up 15% and Hydraulics segment revenue up 3% over first quarter 2023.
  • Strong Performance in Various Markets: Year-over-year sales in agriculture, recreational, mining and Aerospace had solid increases reflecting market diversification efforts and acquisitions.
  • (See the Organic and Acquired Revenue table in this release that provides acquired revenue by segment by quarter).

Airbus Ventures Announces New Investment in Impulse Space

Retrieved on: 
Tuesday, August 1, 2023

Airbus Ventures proudly announces its investment in Impulse Space, Inc. – a leader in the development of in-space transportation services for the inner solar system – which has raised $45 million in its oversubscribed Series A funding round.

Key Points: 
  • Airbus Ventures proudly announces its investment in Impulse Space, Inc. – a leader in the development of in-space transportation services for the inner solar system – which has raised $45 million in its oversubscribed Series A funding round.
  • The round is led by RTX Ventures, with participation from Founders Fund, Lux Capital, Airbus Ventures, Space Capital, and others.
  • (Source: Impulse Space)
    “Space is more accessible than ever, but efficiently moving payloads into higher energy orbits has been a challenge—until now,” explains Impulse Space Founder and CEO Tom Mueller.
  • “Impulse Space is developing a suite of Orbital Transfer Vehicles (OTVs) that will unlock the in-space logistics ecosystem,” remarks Thomas d’Halluin, Airbus Ventures Managing Partner.

Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina

Retrieved on: 
Thursday, July 27, 2023

NEWTOWN, Pa., July 27, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the expansion of the previously announced trial in stroke from 12 to 60 patients. This ongoing investigator-initiated study, led by Dr. Steven Kautz at the Medical University of South Carolina (“MUSC”), will evaluate the effects of cranial-nerve non-invasive neuromodulation (“CN-NINM”), delivered using PoNS Therapy™, on gait and dynamic balance in chronic stroke survivors.

Key Points: 
  • This ongoing investigator-initiated study, led by Dr. Steven Kautz at the Medical University of South Carolina (“MUSC”), will evaluate the effects of cranial-nerve non-invasive neuromodulation (“CN-NINM”), delivered using PoNS Therapy™, on gait and dynamic balance in chronic stroke survivors.
  • “PoNS is already authorized for stroke in Canada, and patients using PoNS Therapy to treat symptoms have seen significant improvement in gait and a reduced risk of falling.
  • Based on this meaningful data, Helius has welcomed the opportunity to support Dr. Kautz’s stroke study by expanding the sample size from twelve to sixty patients,” said Antonella Favit-Van Pelt, M.D., Ph.D., Helius' Chief Medical Officer.
  • MUSC anticipates enrollment of the sixty participants will begin in August 2023, with expected completion by the end of 2024.

Thirteen Web3 Companies Unify Crypto Data With a Single Platform, LiveQuery

Retrieved on: 
Wednesday, July 26, 2023

BOSTON, July 26, 2023 /PRNewswire/ -- The largest network of crypto data and node providers ever assembled is changing the way Web3 leverages data. Launched by data provider Flipside alongside QuickNode, Alchemy, Helius, Footprint, Playgrounds, StrangeLove, DappLooker, Credmark, Blockpour, BitQuery, SubQuery and Chainbase, LiveQuery makes it possible to hit multiple APIs in a single platform with a single SQL query — an industry first.

Key Points: 
  • BOSTON, July 26, 2023 /PRNewswire/ -- The largest network of crypto data and node providers ever assembled is changing the way Web3 leverages data.
  • Launched by data provider Flipside alongside QuickNode, Alchemy, Helius, Footprint, Playgrounds, StrangeLove, DappLooker, Credmark, Blockpour, BitQuery, SubQuery and Chainbase, LiveQuery makes it possible to hit multiple APIs in a single platform with a single SQL query — an industry first.
  • Pair external APIs with data from Flipside and the LiveQuery launch partners, and the scope of possible insights explodes.
  • With an expanding partner network and support for requested APIs, LiveQuery aims to unleash crypto data and empower analysts and firms with unprecedented intelligence.

Impulse Space Secures $45M in Series A Funding Round

Retrieved on: 
Monday, July 24, 2023

Impulse Space, Inc. – a leader in the development of in-space transportation services for the inner solar system – today announced it has secured $45 million in its Series A funding round.

Key Points: 
  • Impulse Space, Inc. – a leader in the development of in-space transportation services for the inner solar system – today announced it has secured $45 million in its Series A funding round.
  • “With the support from RTX Ventures, Impulse Space continues on the path toward its mission to provide agile, economic logistics services in any orbit,” says Impulse Space Founder and CEO Tom Mueller.
  • “It speaks volumes that a leading investment firm is confident in the future of Impulse Space and its trailblazing technology.”
    With an oversubscribed funding round, Impulse Space will be continuing its progress with its work in upcoming missions, such as LEO Express-1, a GEO refueling mission and the upcoming mission to Mars.
  • “Our investment will help Impulse Space accelerate their growth and fuel innovation within the space economy.”
    The Series A funding round also included other participant investors, such as Founders Fund, Lux Capital, Airbus Ventures and Space Capital.

CCC, Groupe Helios deliver first 200 apartments in Dominican Republic

Retrieved on: 
Monday, July 24, 2023

The ceremony was attended by the President of Dominican Republic Luis Abinader, the Director of CAASD Felipe Suberví, the Canadian Chargé d’affaires in the Dominican Republic Collin Holditch, the VP of Operations of CCC Diane Montambault, and the Chairman of the Board of Groupe Helios Jean-Pierre Azzopardi.

Key Points: 
  • The ceremony was attended by the President of Dominican Republic Luis Abinader, the Director of CAASD Felipe Suberví, the Canadian Chargé d’affaires in the Dominican Republic Collin Holditch, the VP of Operations of CCC Diane Montambault, and the Chairman of the Board of Groupe Helios Jean-Pierre Azzopardi.
  • Groupe Helios secured a USD $50M G2G contract to deliver the 1st stage of phase 2 of the Guajimía project through the joint effort of CCC and Canada’s Trade Commissioner Service .
  • In addition to the 200 completed apartments, Groupe Helios is delivering another 144 apartments on a different site.
  • “Groupe Helios is pleased to have delivered the key milestone of 200 completed apartments as planned under the current phase of Guajimia project and stands ready to deliver the next phases of the project.” Jean-Pierre Azzopardi, Chairman of the Board Groupe Helios.

Helios Technologies Announces Retirement of Chief Financial Officer Tricia L. Fulton and Names Sean P. Bagan as Successor

Retrieved on: 
Tuesday, July 18, 2023

“Before I joined Helios, Tricia navigated the Company back from a challenging time in 2020.

Key Points: 
  • “Before I joined Helios, Tricia navigated the Company back from a challenging time in 2020.
  • Her knowledge and expertise of our businesses combined with her steadfast leadership and contributions have been invaluable to Helios.
  • Bagan joins Helios after spending 23 years at Polaris Inc., a global leader in powersports and off-road innovation.
  • With extensive financial management leadership experience, Bagan brings more than 20 years of international business, strategic financial operations, and leadership experience.

Helios Introduces Enhanced Sleeving Capabilities to Boost Portfolio Customization

Retrieved on: 
Tuesday, July 11, 2023

Helios , a firm pioneering the outsourced CIO concept with a suite of quantitative investment management solutions and tools for advisors, today announced the launch of new sleeving capabilities.

Key Points: 
  • Helios , a firm pioneering the outsourced CIO concept with a suite of quantitative investment management solutions and tools for advisors, today announced the launch of new sleeving capabilities.
  • Instead, they gain the ability to customize investment portfolios in line with their overarching philosophies and the specific needs of their clients.
  • “Our enhanced sleeving capability adds a new level of customization, aligning advisors’ models more closely with their brand and philosophy.
  • Advisors interested in learning more about how Helios’ new sleeving capabilities can unlock greater opportunities for customization and client service are encouraged to register for an upcoming webinar, scheduled for July 26th at noon ET/9:00 a.m. PT, here .

Helius Medical Technologies Announces DMEPOS Accreditation for PoNS

Retrieved on: 
Tuesday, June 20, 2023

The accreditation certifies that Helius has established processes that conform to TCT’s Exemplary Provider® DMEPOS Quality Standards.

Key Points: 
  • The accreditation certifies that Helius has established processes that conform to TCT’s Exemplary Provider® DMEPOS Quality Standards.
  • “We are thrilled that PoNS has been awarded DMEPOS accreditation.
  • “DMEPOS accreditation has particular relevance under the proposed Transitional Coverage for Emerging Technologies (TCET) legislation.
  • TCT’s proprietary accreditation status is known as Exemplary Provider Accreditation® and its industry-leading accreditation model features healthcare’s first comprehensive set of plain language, operations-driven quality standards with expert-led implementation guidance.